Trial Profile
A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Registrational; Therapeutic Use
- Sponsors DUSA Pharmaceuticals
- 25 Apr 2021 Results of Phase 3 study assessing acceptability of ALA-PDT vs vehicle-PDT and prior therapy presented at the American Academy of Dermatology Virtual Meeting Experience 2021
- 12 Jun 2020 According to a Sun Pharmaceutical Industries media release, data from post hoc analyses of this trial were presented at American Academy of Dermatology (AAD) Virtual Meeting Experience 2020.
- 14 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.